Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ocugen, Inc. - Common Stock (NQ:OCGN)

1.445 +0.035 (+2.48%)
Streaming Delayed Price Updated: 10:16 AM EST, Feb 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ocugen, Inc. - Common Stock

< Previous 1 2
...
29 30 31 32 33 34 35 36 Next >
News headline image
Will Covaxin's Success Against COVID Variants Make Ocugen a Big Winner? ↗
It's still really early. 
Via The Motley Fool
News headline image
Ocugen or Vaxart: Which Will Take Investors Further? ↗
These two high-flying biotechs are vying for the same market. 
Via The Motley Fool
News headline image
Ocugen Has a Longer Road To Paying off Than People Think ↗
Even after good news in recent days, OCGN stock is right back where it started. And that still doesn't create a buying opportunity. 
Via InvestorPlace
News headline image
Can Ocugen Overcome This Major Hurdle? ↗
It will determine whether the shares sink or skyrocket in the long term. 
Via The Motley Fool
News headline image
Take a Look at Ocugen’s Work on Eye Diseases, Not Just Their Vaccine Partnership ↗
With clinical data to support Ocugen's product candidate to treat multiple eye conditions, OCGN stock isn't just your typical "vaccine stock." 
Via InvestorPlace
News headline image
Could Ocugen Be a Millionaire Maker Stock? ↗
This coronavirus vaccine drugmaker has made investors rich in a very short period. Can it sustain its run? 
Via The Motley Fool
News headline image
FDA To Hold AdCom Meeting For Expanding Use COVID-19 Vaccine In Children ↗
The FDA’s Center for Biologics Evaluation and Research (CBER) will convene a virtual meeting of the Vaccines and Related Biological Products Advisory Committee on June 10... 
Via Benzinga
News headline image
This Is Why Ocugen Crashed Despite Apparent Good News ↗
Ocugen released a bunch of seemingly positive news in recent days. Yet OCGN stock tanked anyway. Here's why you should stay away from it. 
Via InvestorPlace
News headline image
3 Investments That Turned $35,000 Into $1 Million (or More) in Just 6 Months ↗
One security grew $35,000 into more than $9 million since early November. 
Via The Motley Fool
Topics Stocks
News headline image
Ocugen, Inc. (OCGN) Q1 2021 Earnings Call Transcript ↗
OCGN earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
OCGN Stock: Why Red-Hot Ocugen Is Plunging Again Today ↗
Ocugen (OCGN) stock taking a beating on Friday following the release of the biopharmaceutical company's earnings report for Q1 2021. 
Via InvestorPlace
News headline image
Why Ocugen Stock Is Tanking Today ↗
Investors didn't get what they wanted in the biotech's Q1 update. 
Via The Motley Fool
News headline image
Ocugen Stock Has a Big Pullback Coming, and That Will Be Your Chance ↗
OCGN Stock had a nice run in recent weeks but faces risks of a sharp pullback that could lead to paper losses for speculators. 
Via InvestorPlace
News headline image
Ocugen Stock Is a Risky Proposition Despite Its High Valuation ↗
OCGN stock soared on a deal to commercialize Bharat Biotech’s Covaxin in the U.S., but the rollout comes with a lot of challenges. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Gainers Assertio Holdings (NASDAQ:ASRT) shares moved upwards by 32.42% to $0.66 during Friday's pre-market session. The company's market cap stands at $114.5... 
Via Benzinga
News headline image
Does Ocugen Have a Real Shot at the U.S. COVID Vaccine Market? ↗
The biotech faces some big challenges. 
Via The Motley Fool
News headline image
Better Vaccine Stock: Ocugen or Vaxart? ↗
Here's how the biotechs compare on several key fronts. 
Via The Motley Fool
News headline image
72 Biggest Movers From Yesterday ↗
Gainers SemiLEDs Corporation (NASDAQ: LEDS) shares surged 85.8% to settle at $10.22 on above-average volume. Liquidity Services, Inc. (NASDAQ: LQDT) jumped 37.7% to settle at $25... 
Via Benzinga
News headline image
Earnings Scheduled For May 7, 2021 ↗
Companies Reporting Before The Bell • Cronos Group (NASDAQ:CRON) is likely to report earnings for its first quarter. • Eaton Vance Municipal (NYSE:ETX) is... 
Via Benzinga
News headline image
Ocugen Shares Sink Despite OCU200 Being Comparable To Aflibercept In Reducing Neovascularization, Damage To Retina In Animal Study ↗
Ocugen Inc (NASDAQ: OCGN) has announced the presentation of new preclinical data evaluating the efficacy of OCU200 in in-vitro and in-vivo models for ocular... 
Via Benzinga
News headline image
58 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Stealth BioTherapeutics Corp (NASDAQ: MITO) shares surged 92.9% to $2.3150. Stealth BioTherapeutics presented at the Association for Research in Vision and Ophthalmology... 
Via Benzinga
News headline image
OCGN Stock: Why Ocugen Shares Are Stumbling Again Today ↗
OCGN stock is tripping again on Thursday following reports of insider selling and concerns over patent waivers for Covid-19 vaccines. 
Via InvestorPlace
Topics Intellectual Property
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Gainers Stealth BioTherapeutics (NASDAQ:MITO) stock moved upwards by 58.33% to $1.9 during Thursday's pre-market session. The market value of their outstanding shares... 
Via Benzinga
News headline image
30 Stocks Moving in Thursday's Pre-Market Session ↗
Gainers Stealth BioTherapeutics Corp (NASDAQ: MITO) shares rose 94.2% to $2.33 in pre-market trading. Stealth BioTherapeutics showcased data for Elamipretide in dry age-related... 
Via Benzinga
News headline image
Why Ocugen Stock Continues to Be a Great Short Opportunity ↗
No U.S. government official has made positive comments about approving Covaxin and the Covaxin trials do not seem to meet the FDA's preferences. OCGN stock is a short. 
Via InvestorPlace
News headline image
Don’t Chase Ocugen Stock Without Reading the Fine Print ↗
OCGN stock has soared on positive vaccine data. But investors must remember that Ocugen's market and experience are sharply limited. 
Via InvestorPlace
News headline image
Ocugen Looks Perched and Ready to Blow Through $18 ↗
Ocugen had a strong April gaining a whopping 87% for the month. OCGN stock is now up 313% on the year. It seems $18 is just around the corner. 
Via InvestorPlace
News headline image
Can This News Push Ocugen Ahead of Pfizer and Moderna? ↗
Ocugen may be able to handle one of the biggest challenges facing vaccine makers. 
Via The Motley Fool
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
Gainers Cocrystal Pharma (NASDAQ:COCP) stock rose 143.41% to $3.02 during Tuesday's regular session. Trading volume for Cocrystal Pharma's stock is 378.0 million... 
Via Benzinga
News headline image
64 Biggest Movers From Yesterday ↗
Gainers Cocrystal Pharma, Inc. (NASDAQ: COCP) shares surged 72.6% to close at $2.14 on Tuesday. Cocrystal Pharma recently announced progress on its COVID-19 antiviral drug... 
Via Benzinga
< Previous 1 2
...
29 30 31 32 33 34 35 36 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.